Search Results for: STUB1

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
KPNA2 karyopherin subunit alpha 2
  • CaMK IV-mediated phosphorylation of CREB
  • ISG15 antiviral mechanism
  • NS1 Mediated Effects on Host Pathways
  • CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
  • Sensing of DNA Double Strand Breaks
  • Estrogen-dependent gene expression
  • SARS-CoV-1 activates/modulates innate immune responses
  • SARS-CoV-2 activates/modulates innate and adaptive immune responses
LRRK1 leucine rich repeat kinase 1
MAP3K11 mitogen-activated protein kinase kinase kinase 11
  • RAF activation
  • Signaling by moderate kinase activity BRAF mutants
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • CDC42 GTPase cycle
  • RHOG GTPase cycle
  • RHOV GTPase cycle
  • Signaling downstream of RAS mutants
  • Fostamatinib
MAP3K2 mitogen-activated protein kinase kinase kinase 2
  • Bosutinib
  • Fostamatinib
MAP3K21 mitogen-activated protein kinase kinase kinase 21
MAPK3 mitogen-activated protein kinase 3
  • MAPK3 (ERK1) activation
  • RAF-independent MAPK1/3 activation
  • ISG15 antiviral mechanism
  • Signaling by NODAL
  • Spry regulation of FGF signaling
  • Signaling by Activin
  • Frs2-mediated activation
  • ERK/MAPK targets
  • ERK/MAPK targets
  • ERKs are inactivated
  • Regulation of actin dynamics for phagocytic cup formation
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Oxidative Stress Induced Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Oncogene Induced Senescence
  • FCERI mediated MAPK activation
  • Regulation of HSF1-mediated heat shock response
  • NCAM signaling for neurite out-growth
  • RSK activation
  • Signal transduction by L1
  • Activation of the AP-1 family of transcription factors
  • Thrombin signalling through proteinase activated receptors (PARs)
  • Negative regulation of FGFR1 signaling
  • Negative regulation of FGFR2 signaling
  • Negative regulation of FGFR3 signaling
  • Negative regulation of FGFR4 signaling
  • RHO GTPases Activate WASPs and WAVEs
  • RHO GTPases Activate NADPH Oxidases
  • RAF/MAP kinase cascade
  • MAP2K and MAPK activation
  • Negative feedback regulation of MAPK pathway
  • Negative regulation of MAPK pathway
  • Signaling by moderate kinase activity BRAF mutants
  • Signaling by high-kinase activity BRAF mutants
  • Signaling by BRAF and RAF1 fusions
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • RNA Polymerase I Promoter Opening
  • Signal attenuation
  • Interferon gamma signaling
  • Advanced glycosylation endproduct receptor signaling
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • ESR-mediated signaling
  • RUNX2 regulates osteoblast differentiation
  • Regulation of PTEN gene transcription
  • Regulation of the apoptosome activity
  • Estrogen-dependent nuclear events downstream of ESR-membrane signaling
  • Suppression of apoptosis
  • Signaling downstream of RAS mutants
  • Signaling by MAP2K mutants
  • Signaling by RAF1 mutants
  • FCGR3A-mediated phagocytosis
  • Nuclear events stimulated by ALK signaling in cancer
  • IFNG signaling activates MAPKs
  • Negative Regulation of CDH1 Gene Transcription
  • NPAS4 regulates expression of target genes
  • NPAS4 regulates expression of target genes
  • Growth hormone receptor signaling
  • Signaling by LTK in cancer
  • Transcriptional and post-translational regulation of MITF-M expression and activity
  • Sulindac
  • Acetylsalicylic acid
  • Minocycline
  • Arsenic trioxide
  • Colforsin
  • Purvalanol
  • 5-iodotubercidin
  • Seliciclib
  • Cholecystokinin
  • Ulixertinib
MAPT microtubule associated protein tau
  • Caspase-mediated cleavage of cytoskeletal proteins
  • Lansoprazole
  • Astemizole
  • Paclitaxel
  • Docetaxel
  • Flortaucipir F-18
  • Progressive supranuclear palsy (PSP); Steele-Richardson-Olszewski syndrome
  • Frontotemporal lobar degeneration (FTLD), including: Pick disease of brain; Frontotemporal dementia (FTD); Ubiquitin-positive frontotemporal dementia (UP-FTD); Progressive supranuclear palsy type 1 (PSNP1); Inclusion body myopathy with early-onset paget disease and frontotemporal dementia (IBMPFD); Frontotemporal dementia, chromosome 3-linked (FTD3)
  • Amyotrophic lateral sclerosis (ALS); Lou Gehrig's disease
MCF2 MCF.2 cell line derived transforming sequence
  • Axonal growth inhibition (RHOA activation)
  • NRAGE signals death through JNK
  • G alpha (12/13) signalling events
  • RHOA GTPase cycle
  • RHOB GTPase cycle
  • RHOC GTPase cycle
  • CDC42 GTPase cycle
  • RAC1 GTPase cycle
  • RAC2 GTPase cycle
  • RHOG GTPase cycle
  • RAC3 GTPase cycle
METTL14 methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit
  • Processing of Capped Intron-Containing Pre-mRNA
MFHAS1 multifunctional ROCO family signaling regulator 1
MITF melanocyte inducing transcription factor
  • SUMOylation of transcription factors
  • Transcriptional and post-translational regulation of MITF-M expression and activity
  • Malignant melanoma
  • Ocular albinism; Ocular albinism, type I (OA1); Waardenburg syndrome, type II (WS2-OA)
  • Waardenburg syndrome (WS)
MPP1 MAGUK p55 scaffold protein 1
  • Sensory processing of sound by outer hair cells of the cochlea
MST1R macrophage stimulating 1 receptor
  • Signaling by MST1
  • Crizotinib
  • Fostamatinib
MYOCD myocardin
  • Cardiogenesis
NOS1 nitric oxide synthase 1
  • ROS and RNS production in phagocytes
  • Nitric oxide stimulates guanylate cyclase
  • Ion homeostasis
  • Citrulline
  • Donepezil
  • Ketamine
  • L-N(omega)-Nitroarginine-2,4-L-diaminobutyric amide
  • Formic acid
  • 3-Bromo-7-Nitroindazole
  • N-{(4S)-4-Amino-5-[(2-aminoethyl)amino]pentyl}-N'-nitroguanidine
  • N-[3-(aminomethyl)benzyl]acetamidine
  • L-N(omega)-nitroarginine-(4R)-amino-L-proline amide
  • 1-hydroxy-2-isopropylguanidine
  • 7-Nitroindazole
  • N-omega-propyl-L-arginine
  • 2-butyl-1-hydroxyguanidine
  • S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea
  • N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine
  • Flavin adenine dinucleotide
  • Flavin mononucleotide
  • N-(4-{2-[(3-chlorobenzyl)amino]ethyl}phenyl)thiophene-2-carboximidamide
  • Nicotinamide adenine dinucleotide phosphate
  • S-Ethyl-N-Phenyl-Isothiourea
  • [(1S)-4-(1-Aminobutylideneamino)-1-carboxybutyl]azanium
  • 5-N-Allyl-arginine
  • Nitroarginine
  • NXN-188
  • N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE
  • N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine
  • Methylene blue
NQO1 NAD(P)H quinone dehydrogenase 1
  • Regulation of ornithine decarboxylase (ODC)
  • NFE2L2 regulating anti-oxidant/detoxification enzymes
  • Menadione
  • Dicoumarol
  • Duroquinone
  • 3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol
  • ES-936
  • Cibacron Blue
  • Flavin adenine dinucleotide
  • 5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione
  • RH-1
  • Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]
  • 3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2-PHENYL-1H-INDOLE-4,7-DIONE
  • Cannabidiol
NR3C1 nuclear receptor subfamily 3 group C member 1
  • HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand
  • SUMOylation of intracellular receptors
  • PTK6 Expression
  • Regulation of RUNX2 expression and activity
  • FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
  • Potential therapeutics for SARS
  • Regulation of NPAS4 gene transcription
  • Flunisolide
  • Diflorasone
  • Alclometasone
  • Medrysone
  • Amcinonide
  • Fluorometholone
  • Megestrol acetate
  • Levonorgestrel
  • Beclomethasone dipropionate
  • Progesterone
  • Spironolactone
  • Betamethasone
  • Desoximetasone
  • Fluticasone propionate
  • Fluocinolone acetonide
  • Ulobetasol
  • Triamcinolone
  • Prednisone
  • Flumethasone
  • Fludrocortisone
  • Norethisterone
  • Hydrocortisone
  • Mometasone
  • Hydrocortamate
  • Mifepristone
  • Clocortolone
  • Flurandrenolide
  • Prednisolone
  • Loteprednol etabonate
  • Rimexolone
  • Methylprednisolone
  • Clobetasol propionate
  • Fluocinonide
  • Prednicarbate
  • Fluoxymesterone
  • Budesonide
  • Dexamethasone
  • Desonide
  • Cortisone acetate
  • Paramethasone
  • Drospirenone
  • Ciclesonide
  • Hexane-1,6-Diol
  • Aldosterone
  • ORG-34517
  • Difluprednate
  • Ulipristal
  • Fluticasone furoate
  • Tixocortol
  • Difluocortolone
  • Gestrinone
  • Deflazacort
  • Onapristone
  • Cortivazol
  • Clobetasone
  • Fluticasone
  • Mometasone furoate
  • Hydrocortisone aceponate
  • Hydrocortisone acetate
  • Hydrocortisone butyrate
  • Hydrocortisone cypionate
  • Hydrocortisone phosphate
  • Hydrocortisone probutate
  • Hydrocortisone valerate
  • Segesterone acetate
  • Prednisolone phosphate
  • Dexamethasone acetate
  • Betamethasone phosphate
  • Prednisolone acetate
  • 46,XX disorders of sex development (Disorders related to androgen excess), including: Congenital adrenal hyperplasias; Glucocorticoid resistance; Aromatase deficiency
OLFM3 olfactomedin 3
OTUD3 OTU deubiquitinase 3
  • Ovarian tumor domain proteases
  • Regulation of PTEN stability and activity
PA2G4 proliferation-associated 2G4
  • Neutrophil degranulation

Page 4 out of 8 pages